These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30772772)

  • 21. Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation.
    Matassoli FL; Leão IC; Bezerra BB; Pollard RB; Lütjohann D; Hildreth JEK; Arruda LB
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30404938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
    Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice.
    Bode N; Grebe A; Kerksiek A; Lütjohann D; Werner N; Nickenig G; Latz E; Zimmer S
    Biochem Biophys Res Commun; 2016 Sep; 478(1):356-362. PubMed ID: 27416761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis.
    Zhang CJ; Zhu N; Liu Z; Shi Z; Long J; Zu XY; Tang ZW; Hu ZY; Liao DF; Qin L
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158547. PubMed ID: 31678514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis.
    Zhang Y; Gong F; Wu Y; Hou S; Xue L; Su Z; Zhang C
    Nano Lett; 2021 Nov; 21(22):9736-9745. PubMed ID: 34748340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved assay of hepatic microsomal cholesterol 7 alpha-hydroxylase activity by the use of hydroxypropyl-beta-cyclodextrin and an NADPH-regenerating system.
    Souidi M; Parquet M; Lutton C
    Clin Chim Acta; 1998 Jan; 269(2):201-17. PubMed ID: 9526678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue Factor.
    Gravastrand CS; Steinkjer B; Halvorsen B; Landsem A; Skjelland M; Jacobsen EA; Woodruff TM; Lambris JD; Mollnes TE; Brekke OL; Espevik T; Rokstad AMA
    J Immunol; 2019 Aug; 203(4):853-863. PubMed ID: 31270150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation.
    Wu T; Chen X; Wang Y; Xiao H; Peng Y; Lin L; Xia W; Long M; Tao J; Shuai X
    Nanomedicine; 2018 Oct; 14(7):2215-2226. PubMed ID: 29964220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response.
    Montecucco F; Lenglet S; Carbone F; Boero S; Pelli G; Burger F; Roth A; Bertolotto M; Nencioni A; Cea M; Dallegri F; Fraga-Silva RA; Fougère L; Elfakir C; Gassner AL; Rudaz S; Parissaux X; Wils D; Salomé M; Vuilleumier N; Poggi A; Mach F
    Vascul Pharmacol; 2015 Sep; 72():197-208. PubMed ID: 25921922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: Relevance in atherosclerosis.
    Vasamsetti SB; Karnewar S; Gopoju R; Gollavilli PN; Narra SR; Kumar JM; Kotamraju S
    Free Radic Biol Med; 2016 Jul; 96():392-405. PubMed ID: 27156686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary α-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice.
    Sakurai T; Sakurai A; Chen Y; Vaisman BL; Amar MJ; Pryor M; Thacker SG; Zhang X; Wang X; Zhang Y; Zhu J; Yang ZH; Freeman LA; Remaley AT
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28102587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PSRC1 overexpression attenuates atherosclerosis progression in apoE
    Guo K; Hu L; Xi D; Zhao J; Liu J; Luo T; Ma Y; Lai W; Guo Z
    J Mol Cell Cardiol; 2018 Mar; 116():69-80. PubMed ID: 29378206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Nutraceutical Dehydrozingerone and Its Dimer Counteract Inflammation- and Oxidative Stress-Induced Dysfunction of
    Profumo E; Buttari B; D'Arcangelo D; Tinaburri L; Dettori MA; Fabbri D; Delogu G; Riganò R
    Oxid Med Cell Longev; 2016; 2016():1246485. PubMed ID: 28050226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A convenient synthesis of 7 alpha-hydroxycholest-4-en-3-one by the hydroxypropyl-beta-cyclodextrin-facilitated cholesterol oxidase oxidation of 3 beta,7 alpha-cholest-5-ene-3,7-diol.
    Alexander DL; Fisher JF
    Steroids; 1995 Mar; 60(3):290-4. PubMed ID: 7792834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.
    Ou H; Huang Z; Mo Z; Xiao J
    Cardiovasc Toxicol; 2017 Jan; 17(1):1-12. PubMed ID: 27350146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proatherogenic macrophage activities are targeted by the flavonoid quercetin.
    Lara-Guzman OJ; Tabares-Guevara JH; Leon-Varela YM; Álvarez RM; Roldan M; Sierra JA; Londoño-Londoño JA; Ramirez-Pineda JR
    J Pharmacol Exp Ther; 2012 Nov; 343(2):296-306. PubMed ID: 22869926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of alpha-fetoprotein on the activation and phagocytosis of granulocytes and monocytes.
    Kong M; Tian S; Shi H; Zhao J; Feng X; Zheng S; Duan Z; Chen Y
    Hepatogastroenterology; 2012; 59(120):2385-8. PubMed ID: 22709874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.